| Bansal, S., Jonsson, C. B., Taylor, S. L., Figueroa, J. M., Dugour, A. V., & Palacios, C., et al. (2020). Iota-carrageenan and xylitol inhibit sars-cov-2 in cell culture. bioRxiv. |
 
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 21/11/2020, 13:30 |
|
| Berezhnoy, G., Bissinger, R., & Liu, A. (2023). Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term covid-19 syndrome (ltcs) patients. bioRxiv. |
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 30/01/2023, 11:38 |
|
| Boumaza, A., Gay, L., Mezouar, S., Diallo, A. B., Michel, M., & Desnues, B., et al. (2020). Monocytes and macrophages, targets of SARS-CoV-2: the clue for Covid-19 immunoparalysis. bioRxiv, 2020.09.17.300996. |
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 21/09/2020, 20:27 |
|
| Bukkuri, A., & Adler, F. R. (2023). Mathematical Modeling of Field Cancerization through the Lens of Cancer Behavioral Ecology. bioRxiv. |
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 12/07/2025, 01:22 |
|
| Frasson, I., Diamante, L., & Zangrossi, M. (2023). Identification of druggable host dependency factors shared by multiple sars-cov-2 variants of concern. bioRxiv. |
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 12/01/2023, 10:33 |
|
| Goudswaard, L. J., & Williams, C. M. (2022). Alterations in platelet proteome signature and impaired platelet integrin αiibβ3 activation in patients with covid-19. bioRxiv. |
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 23/10/2022, 14:15 |
|
| He, C., Simpson, C., & Cossentino, I. M. =. F. (2025). Cell signaling pathways discovery from multi-modal data. bioRxiv, 2025.02.06.636961. |
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 17/06/2025, 18:39 |
|
| Moakes, R. J. A., Davies, S. P., Stamataki, Z., & Grover, L. M. (2020). Formulation of a composite nasal spray enabling enhanced surface coverage and prophylaxis of SARS-COV-2. bioRxiv, 2020.11.18.388645. |
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 01/12/2020, 11:17 |
|
| Ogharandukun, E., Tewolde, W., Damtae, E., & others. (2020). Velcro-like mannose and slime-like sialic acid interactions guide self-adhesion and aggregation of virus n-glycan shields. bioRxiv, 2020.05.01.072769. |
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 03/07/2021, 15:52 |
|
| Proud, P. C., Tsitoura, D., Watson, R. J., Chua, B. Y., Aram, M. J., & Bewley, K. R., et al. (2020). Prophylactic intranasal administration of a TLR2 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model. bioRxiv. |
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 11/11/2020, 17:50 |
|
| Saito, A., Nasser, H., Uriu, K., & others. (2021). Sars-cov-2 spike p681r mutation enhances and accelerates viral fusion. bioRxiv. |
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 24/06/2021, 10:49 |
|
| Schäfer, A., Muecksch, F., Lorenzi, J. C. C., Leist, S. R., Cipolla, M., & Bournazos, S., et al. (2020). Antibody potency, effector function and combinations in protection from sars-cov-2 infection in vivo. bioRxiv. |
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 18/09/2020, 14:33 |
|
| Tortorici, A. M., Addetia, A., & Seo, A. J. (2023). Persistent immune imprinting after xbb.1.5 covid vaccination in humans. bioRxiv. |
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 01/12/2023, 12:44 |
|
| Vick, S. C., Domenjo-Vila, E., & Frutoso, M. (2025). Mucosal tissue NK cells tune their function between optimal anti-pathogen activity and tissue protection. bioRxiv. |
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 24/12/2025, 18:17 |
|
| Wu, Z., Pope, S. D., & Medzhitov, R. (2025). Control of inflammatory response by tissue microenvironment. bioRxiv. |
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 14/09/2025, 19:54 |
|
| Zhu, L., Deng, Y. -Q., Zhang, R. -R., Cui, Z., Sun, C. -Y., & Fan, C. -F., et al. (2020). Double Lock of a Potent Human Monoclonal Antibody against SARS-CoV-2. bioRxiv, 2020.11.24.393629. |
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 29/11/2020, 10:19 |
|
